Search results for " Streptococcus pneumoniae"

showing 4 items of 4 documents

International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

2019

Objective: Streptococcus pneumoniae is the most frequent bacterial pathogen isolated in subjects with Community-acquired pneumonia (CAP) worldwide. Limited data are available regarding the current global burden and risk factors associated with drug-resistant Streptococcus pneumoniae (DRSP) in CAP subjects. We assessed the multinational prevalence and risk factors for DRSP-CAP in a multinational point-prevalence study. Design: The prevalence of DRSP-CAP was assessed by identification of DRSP in blood or respiratory samples among adults hospitalized with CAP in 54 countries. Prevalence and risk factors were compared among subjects that had microbiological testing and antibiotic susceptibility…

0301 basic medicineMaleStreptococcus pneumoniaantibiotic resistanceInternationalitysputum examinationbronchiectasisvery elderlyAntibioticsPrevalenceDrug resistancemedicine.disease_causeLogistic regressionGlobal HealthCommunity-Acquired Infections/epidemiologylung lavage0302 clinical medicineCommunity-acquired pneumoniaCost of IllnessRisk FactorsPrevalencedrug resistant Streptococcus pneumoniae pneumonia030212 general & internal medicineMicrobial drug resistantAged 80 and overadultinternational cooperationdrug effectMiddle Agedinfluenza vaccinationAnti-Bacterial Agentsantiinfective agentEuropeCommunity-Acquired InfectionsHospitalizationGlobal burden of diseaseStreptococcus pneumoniaeInfectious Diseasesrisk factorbacterium identificationFemalecommunity acquired infectioninfluenzaliver diseasepneumococcal vaccinationPneumococcal infectionhospitalizationmedicine.drugMicrobiology (medical)medicine.medical_specialtyAsiamedicine.drug_class030106 microbiologySettore MED/10 - Malattie Dell'Apparato RespiratorioArticleAnti-Bacterial Agents/pharmacology03 medical and health sciencesInternal medicineStreptococcus pneumoniaeDrug Resistance BacterialPneumonia Pneumococcal/epidemiologymedicineHumanscontrolled studyhumantetracyclineHospitalization/statistics & numerical dataAgedlevofloxacinnonhumanbusiness.industrydisease associationmicrobiologycommunity acquired pneumoniamacrolidePneumoniaasthmaSouth AmericaPneumonia Pneumococcalvaccinationmedicine.diseasemajor clinical studyantibiotic sensitivitypenicillin derivativePenicillinStreptococcus pneumoniae/drug effectsPneumoniablood examinationAfricaNorth Americamicrobiological examinationbusinessGlobal burden of disease; Microbial drug resistant; Pneumococcal infection; Pneumonia
researchProduct

Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in…

2017

The spread of Streptococcus pneumoniae within families has been scarcely investigated so far. This feasibility study aimed to estimate the prevalence of pneumococcal carriage in school-aged children and co-habiting relatives and to explore the potential link between the family environment and the sharing of pneumococcal serotypes covered by the vaccine. Oropharyngeal samples of 146 subjects belonging to 36 different family groups were molecularly tested for pneumococcal detection and serotyping. The overall prevalence of pneumococcal carriage was 65.8% (n = 96/146), whereas it was higher among schoolchildren (77.8%, n = 28/36); subjects of seven years of age had the highest odds of being co…

0301 basic medicineSerotypeMalePediatricsfamilymedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataPneumococcal Vaccineslcsh:Chemistry0302 clinical medicineColonizationChild<i>Streptococcus pneumoniae</i>; conjugate vaccine; serotypes; schoolchildren; family; carriage; colonization; horizontal transmission; real-time PCRSicilylcsh:QH301-705.5SpectroscopyschoolchildrenGeneral MedicineMiddle AgedComputer Science ApplicationsStreptococcus pneumoniae030220 oncology & carcinogenesisChild Preschoolconjugate vaccinePopulation studyFemaleHorizontal transmissionAdultmedicine.medical_specialtyAdolescentContext (language use)CatalysisPneumococcal InfectionsArticleInorganic Chemistry03 medical and health sciencesYoung AdultSerotypeConjugate vaccineStreptococcus pneumoniaemedicineHumansPhysical and Theoretical ChemistrySerotypingMolecular BiologycarriageVaccines Conjugatebusiness.industryOrganic ChemistryOdds ratiohorizontal transmissioncolonization030104 developmental biologyserotypeslcsh:Biology (General)lcsh:QD1-999Feasibility StudiesImmunizationCarriage; Colonization; Conjugate vaccine; Family; Horizontal transmission; Real-time PCR; Schoolchildren; Serotypes; Streptococcus pneumoniaebusinessreal-time PCRDemographyInternational Journal of Molecular Sciences; Volume 18; Issue 1; Pages: 105
researchProduct

Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination s…

2014

Streptococcus pneumoniae is a major cause of human infectious diseases worldwide. Despite this documented evidence, data on pneumococcal disease rates among general populations are scant because of the frequent lack of cultural identification. In this study we propose a model for estimating the burden of pneumococcal pneumonia on hospitalizations. The study was performed by analyzing administrative and clinical data of patients aged 50 years or older, resident in Sicily, and hospitalized, from 2005 to 2012. Demographic information, admission/discharge dates, discharge status, and up to 6 discharge diagnoses coded according to ICD-9 CM were collected for each hospitalized patient. During the…

MalePediatricsmedicine.medical_specialtyImmunologyPopulationSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causePneumococcal VaccinesCost of IllnessHealth careStreptococcus pneumoniaemedicineHumansImmunology and AllergyeducationSicilyAgedAged 80 and overPharmacologyeducation.field_of_studySicily Streptococcus pneumoniae hospitalizations model estimating pneumococcal pneumoniabusiness.industryVaccinationBudget impactMiddle AgedPneumonia Pneumococcalmedicine.diseaseHospitalizationVaccinationPneumoniaPopulation SurveillancePneumococcal pneumoniaFemaleDiagnosis codebusinessResearch PaperHuman Vaccines &amp; Immunotherapeutics
researchProduct

Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study

2022

Pneumococcal community-acquired pneumonia (CAP) is a leading cause of mortality. Following the introduction of pneumococcal conjugate vaccines (PCVs) in children, a decrease in the burden of the disease was reported. In parallel, an increase in non-vaccine serotypes was also noted. The objective of this study was to assess the current serotype-specific epidemiology of pneumococci among Italian older adults hospitalized for CAP. A prospective study was conducted between 2017 and 2020 in four Italian regions. Subjects aged ≥65 years hospitalized with confirmed CAP were tested for pneumococci using both pneumococcal urinary antigen and serotype-specific urine antigen tests able to identify all…

pneumococcal conjugate vaccinecommunity-acquired pneumonia (CAP); older adults; pneumococcal conjugate vaccines; pneumococcal pneumonia; Streptococcus pneumoniaeMicrobiology (medical)Streptococcus pneumoniaepneumococcal pneumoniaVirologypneumococcal conjugate vaccinescommunity-acquired pneumonia (CAP)community-acquired pneumonia (CAP); <i>Streptococcus pneumoniae</i>; pneumococcal pneumonia; pneumococcal conjugate vaccines; older adultsSettore MED/42 - Igiene Generale E ApplicataMicrobiologyolder adultsMicroorganisms
researchProduct